Tamoxifen Metabolite Concentrations, CYP2D6 Genotype and Breast Cancer Outcomes

We explored whether breast cancer outcomes are associated with endoxifen and other metabolites of tamoxifen, and to examine potential correlates of endoxifen concentrations including CYP2D6 metabolizer phenotype and body mass index (BMI). Tamoxifen, endoxifen, 4-hydroxytamoxifen and N-desmethyltamox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Madlensky, Lisa, Natarajan, Loki, Tchu, Simone, Pu, Minya, Mortimer, Joanne, Flatt, Shirley W., Nikoloff, D. Michele, Hillman, Grantland, Fontecha, Marcel R., Lawrence, H. Jeffrey, Parker, Barbara A., Wu, Alan H.B., Pierce, John P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3081375/
https://ncbi.nlm.nih.gov/pubmed/21430657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2011.32
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados